Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON)

Journal of Biological Regulators and Homeostatic Agents

Volumn 18, Issue 3-4, 2004, Pages 313-326

  van Wering, E R ^a   van Lochem, E G ^b   Leenders, M ^c   van der Sluijs Gelling, A J ^a   Wind, H ^b   Gratama, J W ^b   Kraan, J ^b   Preijers, F W M B ^c  

^a DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Flowcytometry; Leukemia; Lymphoma; Multi parameter immunophenotyping; Standardization

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD36 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; STEM CELL FACTOR RECEPTOR;

ANTIBODY SCREENING; ARTICLE; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NETHERLANDS; PRACTICE GUIDELINE; STANDARDIZATION; T LYMPHOCYTE; BLOOD DISEASE; CLASSIFICATION; IMMUNOLOGY; METHODOLOGY; STANDARD;

FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOPHENOTYPING;

EID: 17844374598     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rothe G, Schmitz G, for the Working Group on Flow Cytometry and Image Analysis. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 1996; 10: 877-95.
2. Lucio P, Parreira A, van den Beemd MWM, et al. Flow cytometric analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia 1999; 13: 419-27.
3. Porwit-MacDonald A, Bjorkland E, van Lochem EG, et al. A. BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukemia 2000; 14: 816-25.
4. Lucio P, Gaipa G, van Lochem EG, et al. A. BIOMED-1 concerted action report: Flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. Leukemia 2001; 15: 1185-92.
5. Basso G, Bernasconi P, Chianese R, et al. Monoclonal antibody panels for acute leukemia and myelodysplastic syndrome diagnosis. Results of a co-operative quality group. J Biol Regul Homeost Agents 2001; 15: 145-55.
6. Gratama JW, D'Hautcourt JL, Mandy F, et al for the European Working Group on Clinical Cell Analysis. Flow cytometric quantitation of immunofluorescence intensity: Problems and perspectives. Cytometry 1998; 33: 166-78.
7. Gratama JW, Kraan J, Adriaansen H, et al. Reduction of interlaboratory variability in flow cytometric immunophenotyping by standardization of instrument set-up and calibration, and standard list mode data analysis. Cytometry 1997; 30: 10-22.
8. Kraan J, Gratama JW, Keeney M, D'Hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Regul Homeost Agents 2003; 17: 223-33.
9. Kluin-Nelemans JC, van Wering ER, van 't Veer MB, et al. Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: Survey of 9 years of quality control in the Netherlands. Br J Haematol 1996; 95: 692-9.
10. Kluin-Nelemans JC, van Wering ER, van der Schoot CE, et al. SIHONSCORE: A scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance. Br J Haematol 2001; 112: 337-43.
11. Borowitz MJ, Bray R, Gascoyne R, et al. U.S.-Canadian Consensus recomendations on the immunophenotypic analysis of hematologic neoplasia by flowcytometry: Data analysis and interpretation. Cytometry 1997; 30: 236-44.
12. van Lochem EG, van der Velden VHJ, Wind HK, et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-induced shift. Leukemia (in press).
13. Orfao A, Schmitz G, Brando B, et al. Clinical useful information provided by the flow cytometric immunophenotyping of hematological malignancies: Current status and future directions. Clinical Chemistry 1999: 45: 1708-17.
14. Szczepanski T, van der Velden VHJ, van Dongen JJM. Classification systems for acute and chronic leukaemias. Best Practice and Research Clin Haematology 2003; 16: 561-82.
15. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 1993; 100: 534-40.
16. van Lochem EG, Wiegers YM, van den Beemd R, et al. Regeneration pattern of precursor-B-cells in bone marrow of ALL patients depends on the type of preceding chemotherapy. Leukemia 2000; 14: 688-95.
17. van Wering ER, van der Linden-Schrever BE, Szczepanski T, et al. Regenerating normal B-cell precursors during and after treatment of ALL: Implications for monitoring of minimal residual disease. Br J Haematol 2000; 110: 139-46.